Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants

AIDS Patient Care and STDs

Volumn 27, Issue 6, 2013, Pages 320-325

  Adeyemi, Oluwatoyin M ^a,b   Livak, Britt ^a   Orsi, Jennifer ^a   Glesby, Marshall J ^c   Villacres, Maria C ^d   Weber, Kathleen M ^a   Sharma, Anjali ^e   Golub, Elizabeth ^f   Young, Mary ^g   Cohen, Mardge ^a,b   Tien, Phyllis C ^h  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIRETROVIRUS AGENT; EFAVIRENZ; GLUCOSE; INSULIN; PROTEINASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIV INFECTIONS; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84878571800     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0400     Document Type: Article

References (29)

1. Chiu KC, Chu A, Go VL, and Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-825.
2. MattilaC,Knekt P,Mannisto S, et al. Serum25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569-2570.
3. Ford ES, Ajani UA, McGuire LC, and Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-1230.
4. Takiishi T, Gysemans C, Bouillon R, and Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am 2010;39: 419-446.
5. Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33: 1379-1381.
6. Pinelli NR, Jaber LA, Brown MB, and Herman WH. Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010;33:1373-1375.
7. Pittas AG, Lau J, Hu FB, and Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92: 2017-2029.
8. Scragg R, Sowers M, Bell C, et al. Serum 25-hydroxyD, diabetes and ethnicity in the third National Health and Nutrition examination survey. Diabetes Care 2004;27:2813- 2818.
9. Tien PC, Schneider MF, Cole SR, et al. Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2008;49:369-376.
10. Koster JC, Remedi MS, Qiu H, Nichols CG, and Hruz PW. HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 2003;52:1695-1700.
11. Brown TT, Li X, Cole SR, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 2005;19:1375-1383.
12. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375-1382.
13. Bang UC, Shakar SA, Hitz MF, et al. Deficiency of 25- hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study. Scand J Infect Dis 2010;42:306-310.
14. Dao CN, Patel P, Overton TE, et al. Low vitamin D among HIV-infected adults: Prevalence of and risk factors for low vitamin D levels in a cohort of HIV-Infected adults and comparison to prevalence among adults in the general US population. Clin Infect Dis 2011;52:396-405.
15. Peter Wasserman RD, and David S Rubin. Highly prevalent Vitamin D deficiency and insufficiency in an urban cohort of HIV-infectedmen under care.AIDS Patient Care STDs 2010;24: 223-227.
16. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIV-infected and un-infected women in the US. J Acquir Immune Defic Syndr 2011;57:197-204.
17. Szep Z, Guaraldi G, Shah SS, et al. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2011;25:525-529.
18. Hammond E, McKinnon E, and Glendenning P. Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clin Endocrinol (Oxf) 2012;76:201-206.
19. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV study. WIHS Collaborative study group. Epidemiology 1998;9:117-125.
20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
21. Asasco JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-3325.
22. Muscogiuri G, Sorice GP, Prioletta A, et al. 25- Hydroxyvitamin D concentration correlates with insulinsensitivity and BMI in obesity. Obesity (Silver Spring) 2010;8:1906-1910.
23. Alvarez JA and Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351-385.
24. Dube MP, Edmondson-Melancon H, Qian D, et al. Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIVinfected patients. J Acquir Immune Defic Syndr 2001;27:130- 134.
25. Walli R, Goebel FD, and Demant T. Impaired glucose tolerance and protease inhibitors. Ann Intern Med 1998;129: 837-838.
26. Brown TT, Tassiopoulos K, Bosch R, et al. Association between systemic inflammation and incident diabetes in HIVinfected patients after initiation of antiretroviral therapy. Diabetes Care 2010;33:2244-2249.
27. Mehta S, Mugusi FM, Spiegelman D, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDs 2011; 25:579-585.
28. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
29. Hanson RL, Pratley RE, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190- 198.